论文部分内容阅读
随着肝血管介入治疗的广泛开展,肝动脉化疗栓塞术已成为不能手术切除的肝癌患者的首选治疗力法。无论是在肿瘤缩小、甲胎蛋白下降等疗效的观察,还是在生存率、生存质量的评价方面,肝癌的介入治疗效果都是确切的。下面就近几年来中西医结合肝癌介入治疗的进展作简要的概述。 1 介入治疗的原理及其对机体的不良影响 1.1 介入治疗原理 正常肝脏有两套供血系统,即肝动脉和门静脉,而肝癌的血供主要是来源于肝动脉系统。肝癌的介入治疗是在肝动脉造影的基础上发展起来的。应用Seldingeg技术,经股动脉引入动脉导管,选择性地将导管插入到肝癌的供血动脉,这样动脉导管一端连着肿块,另一端连向体外,我们在
With the extensive interventional treatment of hepatic vessels, transcatheter arterial chemoembolization has become the preferred method of treatment for patients with unresectable liver cancer. Whether in tumor shrinkage, alpha-fetoprotein decline and other effects of observation, or in the survival rate, quality of life evaluation, the interventional treatment of liver cancer effect is accurate. The following in recent years the progress of interventional treatment of liver cancer with traditional Chinese and Western medicine for a brief overview. Interventional treatment of the principle and its adverse effects on the body 1.1 The principle of interventional treatment There are two normal liver blood supply system, namely the hepatic artery and portal vein, and liver cancer mainly from the hepatic artery blood supply. Interventional treatment of liver cancer is based on the development of hepatic artery angiography. The application of Seldingeg technology, the introduction of the femoral artery catheter, the catheter is selectively inserted into the hepatic artery supply, so that one end of the catheter attached to the mass, the other end connected to the body, we are in the